blank LMU Munich Faculty for Chemistry and Pharmacy

ERC Projects


Since February 2022, we have been funded by an ERC-Proof-of-Concept grant "RNhale" to develop dry powder formulations of RNA-loaded nanoparticles by spray drying. The project logically builds upon our ERC-StG project "Novel Asthma Therapy" with the aim of refining, translating and exploiting our findings. (Figure credits to Dr. Ben Winkeljann)

The project has a clear aim of assessing the commercial positioning of a platform technology for spray-drying RNA and of refining existing protocols for spray-drying RNA NPs made with diverse RNA NPs to overcome current challenges of storage and transport conditions as well as delivery beyond the liver.

Project-related publications:

"Novel Asthma Therapy"

From October 2015 until December 2021, we have developed dry powder platform technologies for targeted pulmonary siRNA delivery to activated T cells in the lung under the ERC Starting Grant ERC-2014-StG – 637830 "Novel Asthma Therapy".

The project had a clear aim of advancing pulmonary nanomedicine as novel asthma therapy specifically and RNA delivery in general.

Project-related publications: